“A serious breakthrough in the lab,” began the tweet worth more than $8 million to a micro-cap London biotech company.
The tweet, posted Sunday and totaling 50 characters, sent HemoGenyx Pharmaceuticals’ share price up nearly three-fold on Monday morning, making it the day’s best performing company on the London Stock Exchange.
About the Author Reprints
